Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans. - PubMed - NCBI

Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans. - PubMed - NCBI

J Am Coll Cardiol. 2017 Mar 28;69(12):1564-1574. doi: 10.1016/j.jacc.2017.01.040.

Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.

Nadkarni GN1, Galarneau G1, Ellis SB1, Nadukuru R1, Zhang J1, Scott SA1, Schurmann C1, Li R2, Rasmussen-Torvik LJ3, Kho AN3, Hayes MG4, Pacheco JA3, Manolio TA2, Chisholm RL3, Roden DM5, Denny JC5, Kenny EE1, Bottinger EP6.

Author information

Abstract

BACKGROUND:

African Americans (AA) are disproportionately affected by hypertension-related health disparities. Apolipoprotein L1 (APOL1) risk variants are associated with kidney disease in hypertensive AAs.

OBJECTIVES:

This study assessed the APOL1 risk alleles' association with blood pressure traits in AAs.

METHODS:

The discovery cohort included 5,204 AA participants from Mount Sinai's BioMe biobank. Replication cohorts included additional BioMe (n = 1,623), Vanderbilt BioVU (n = 1,809), and Northwestern NUgene (n = 567) AA biobank participants. Single nucleotide polymorphisms determining APOL1 G1 and G2 risk alleles were genotyped in BioMe and imputed in BioVU/NUgene participants. APOL1 risk alleles' association with blood pressure-related traits was tested in the discovery cohort, a meta-analysis of replication cohorts, and a combined meta-analysis under recessive and additive models after adjusting for age, sex, body mass index, and estimated glomerular filtration rate.

RESULTS:

There were 14% to 16% of APOL1 variant allele homozygotes (2 copies of G1/G2) across cohorts. APOL1 risk alleles were associated under an additive model with systolic blood pressure (SBP) and age at diagnosis of hypertension, which was 2 to 5 years younger in the APOL1 variant allele homozygotes (Cox proportional hazards analysis, p value for combined meta-analysis [pcom] = 1.9 × 10-5). APOL1 risk alleles were associated with overall SBP (pcom = 7.0 × 10-8) and diastolic blood pressure (pcom = 2.8 × 10-4). After adjustment for all covariates, those in the 20- to 29-year age range showed an increase in SBP of 0.94 ± 0.44 mm Hg (pcom = 0.01) per risk variant copy. APOL1-associated estimated glomerular filtration rate decline was observed starting a decade later in life in the 30- to 39-year age range.

CONCLUSIONS:

APOL1 risk alleles are associated with higher SBP and earlier hypertension diagnoses in young AAs; this relationship appears to follow an additive model.

Copyright © 2017 American College of Cardiology Foundation. All rights reserved.

KEYWORDS:

APOL1; allele; estimated glomerular filtration rate; genetic association studies; kidney disease

PMID:

 

28335839

 

DOI:

 

10.1016/j.jacc.2017.01.040

Last Posted: Mar 30, 2017

---

• Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.  
  Nadkarni Girish N et al. Journal of the American College of Cardiology 2017 Mar 69(12) 1564-1574
• Genomics, Health Disparities, and Missed Opportunities for the Nation’s Research Agenda,  
  West KM, et al. JAMA March 27, 2017
• H3Africa: Fostering Collaboration  
  F Collins, NIH Director, March 23, 2017
• Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.  
  Cragun Deborah et al. Expert review of molecular diagnostics 2017 Jan 17(1) 57-70
• Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients.  
  Joseph Galen et al. Journal of genetic counseling 2017 Mar
• Equity in Precision Medicine: Is It Within Our Reach?  
  Armstrong Katrina et al. Journal of the National Comprehensive Cancer Network : JNCCN 2017 Mar 15(3) 421-423
• Accelerators: Sparking Innovation and Transdisciplinary Team Science in Disparities Research.  
  Horowitz Carol R et al. International journal of environmental research and public health 2017 Feb 14(3)
• Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.  
  Cragun Deborah et al. Cancer 2017 Feb
• Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors  
  D Cragun et al, Cancer, February 9, 10`7
• "They Just Want to Know" - Genetic Health Professionals' Beliefs About Why Parents Want to Know their Child's Carrier Status.  
  Vears Danya F et al. Journal of genetic counseling 2017 Feb
• Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.  
  Campbell Joshua D et al. JAMA oncology 2017 Jan
• Non-European populations still underrepresented in genomic testing samples: Dearth of African-American, Latino, and other non-European groups contributes to healthcare, research disparities.  
   et al. American journal of medical genetics. Part A 2017 Feb 173(2) 296-297
• Pharmacogenomic challenges in cardiovascular diseases: examples of drugs and considerations for future integration in clinical practice.  
  Chatelin Jérôme et al. Current pharmaceutical biotechnology 2017 Jan
• Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach.  
  Culhane-Pera Kathleen A et al. Journal of community genetics 2017 Jan
• In Cancer Trials, Minorities Face Extra Hurdles  
  D Grady, New York Times, December 23, 2016
• Clinical Cancer Genetics Disparities among Latinos.  
  Cruz-Correa Marcia et al. Journal of genetic counseling 2016 Dec

more